DK1496904T3 - Anvendelse af lægemidler indeholdende N,N'-disubstituerede piperazinforbindelser - Google Patents
Anvendelse af lægemidler indeholdende N,N'-disubstituerede piperazinforbindelserInfo
- Publication number
- DK1496904T3 DK1496904T3 DK02796584T DK02796584T DK1496904T3 DK 1496904 T3 DK1496904 T3 DK 1496904T3 DK 02796584 T DK02796584 T DK 02796584T DK 02796584 T DK02796584 T DK 02796584T DK 1496904 T3 DK1496904 T3 DK 1496904T3
- Authority
- DK
- Denmark
- Prior art keywords
- drugs containing
- piperazine compounds
- disubstituted piperazine
- disubstituted
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10161809A DE10161809A1 (de) | 2001-12-14 | 2001-12-14 | Arzneimittel enthaltend N,N'-disubstituierte Piperazin-Verbindungen |
| PCT/EP2002/013911 WO2003051369A1 (de) | 2001-12-14 | 2002-12-09 | Arzneimittel enthaltend n, n'-disubstituierte piperazin-verbindungen und ihre verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1496904T3 true DK1496904T3 (da) | 2007-11-12 |
Family
ID=7709439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02796584T DK1496904T3 (da) | 2001-12-14 | 2002-12-09 | Anvendelse af lægemidler indeholdende N,N'-disubstituerede piperazinforbindelser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7816358B2 (da) |
| EP (1) | EP1496904B1 (da) |
| JP (1) | JP2005519037A (da) |
| AR (1) | AR037834A1 (da) |
| AT (1) | ATE369859T1 (da) |
| AU (1) | AU2002361988A1 (da) |
| CA (1) | CA2469944A1 (da) |
| CY (1) | CY1106964T1 (da) |
| DE (2) | DE10161809A1 (da) |
| DK (1) | DK1496904T3 (da) |
| ES (1) | ES2291528T3 (da) |
| HU (1) | HUP0500085A2 (da) |
| PE (1) | PE20030770A1 (da) |
| PL (1) | PL370659A1 (da) |
| PT (1) | PT1496904E (da) |
| WO (1) | WO2003051369A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10161644A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | N,N'-disubstituierte Piperazin-Verbindungen |
| UY28538A1 (es) * | 2003-09-26 | 2005-04-29 | Vertex Pharma | Derivados de fenil-piperazina como moduladores de receptores muscarínicos |
| US20050244517A1 (en) * | 2003-11-05 | 2005-11-03 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
| WO2008151156A1 (en) * | 2007-05-31 | 2008-12-11 | Sepracor Inc. | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3716538A (en) * | 1970-09-09 | 1973-02-13 | Miles Lab | Aminomethylphenylbicyclononenols |
| GB1560271A (en) * | 1977-01-14 | 1980-02-06 | Joullie International Sa | Therapeutically useful m-trifluoromethylphenylpiperazine derivatives |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| UA66370C2 (en) * | 1997-12-16 | 2004-05-17 | Lilly Co Eli | Arylpiperazines having activity to setotonin 1 receptors |
| EP1031350A1 (en) * | 1999-02-23 | 2000-08-30 | Warner-Lambert Company | Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain |
| DE19915601A1 (de) * | 1999-04-07 | 2000-10-19 | Gruenenthal Gmbh | 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung |
| DE19963175A1 (de) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Verwendung von substituierten 4-Amino-1-phenylbutan-2-ol-Verbindungen als Arzneimittel |
| DE10161644A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | N,N'-disubstituierte Piperazin-Verbindungen |
| DE10236510A1 (de) * | 2002-08-09 | 2004-02-19 | Grünenthal GmbH | Verfahren zur Herstellung von 2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol |
-
2001
- 2001-12-14 DE DE10161809A patent/DE10161809A1/de not_active Withdrawn
-
2002
- 2002-12-09 HU HU0500085A patent/HUP0500085A2/hu unknown
- 2002-12-09 PT PT02796584T patent/PT1496904E/pt unknown
- 2002-12-09 WO PCT/EP2002/013911 patent/WO2003051369A1/de not_active Ceased
- 2002-12-09 DE DE50210727T patent/DE50210727D1/de not_active Expired - Lifetime
- 2002-12-09 ES ES02796584T patent/ES2291528T3/es not_active Expired - Lifetime
- 2002-12-09 EP EP02796584A patent/EP1496904B1/de not_active Expired - Lifetime
- 2002-12-09 AU AU2002361988A patent/AU2002361988A1/en not_active Abandoned
- 2002-12-09 AT AT02796584T patent/ATE369859T1/de active
- 2002-12-09 CA CA002469944A patent/CA2469944A1/en not_active Abandoned
- 2002-12-09 PL PL02370659A patent/PL370659A1/xx not_active Application Discontinuation
- 2002-12-09 JP JP2003552302A patent/JP2005519037A/ja not_active Withdrawn
- 2002-12-09 DK DK02796584T patent/DK1496904T3/da active
- 2002-12-13 AR ARP020104854A patent/AR037834A1/es unknown
- 2002-12-13 PE PE2002001212A patent/PE20030770A1/es not_active Application Discontinuation
-
2004
- 2004-06-14 US US10/866,100 patent/US7816358B2/en not_active Expired - Fee Related
-
2007
- 2007-10-30 CY CY20071101395T patent/CY1106964T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE369859T1 (de) | 2007-09-15 |
| US7816358B2 (en) | 2010-10-19 |
| WO2003051369A1 (de) | 2003-06-26 |
| EP1496904A1 (de) | 2005-01-19 |
| US20050038034A1 (en) | 2005-02-17 |
| PT1496904E (pt) | 2007-09-26 |
| PE20030770A1 (es) | 2003-09-27 |
| JP2005519037A (ja) | 2005-06-30 |
| ES2291528T3 (es) | 2008-03-01 |
| PL370659A1 (en) | 2005-05-30 |
| AR037834A1 (es) | 2004-12-09 |
| DE10161809A1 (de) | 2003-06-26 |
| CA2469944A1 (en) | 2003-06-26 |
| AU2002361988A1 (en) | 2003-06-30 |
| EP1496904B1 (de) | 2007-08-15 |
| HUP0500085A2 (hu) | 2005-05-30 |
| CY1106964T1 (el) | 2012-05-23 |
| DE50210727D1 (de) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50212273D1 (de) | Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen | |
| ATE296619T1 (de) | Feste orale dosierungsform von simethicon | |
| ATE349431T1 (de) | Herstellung von aminopyrimidinverbindungen | |
| DK1360169T3 (da) | Succinatsalt af O-desmethyl-venlafaxin | |
| BR0213991B1 (pt) | cartucho de seringa dobrÁvel | |
| DE60111734D1 (de) | [1,4']-bipiperidin verbindungen | |
| DK1438306T3 (da) | Derivater af UK-2A | |
| DE60201859D1 (de) | Pharmazeutische Verwendung von N-Carbamoylazol-Derivate | |
| DE50212029D1 (de) | Kosmetische zubereitung enthaltend polycarbonate | |
| EE200300167A (et) | Amidoalküülpiperidiini ja -piperasiini derivaadid, neid sisaldav farmatseutiline kompositsioon ningühendite kasutamine närvisüsteemi häirete raviks | |
| DE60024233D1 (de) | Verwendung kationischer Verbindungen | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
| DE60220914D1 (de) | Aminoacetonitril-verbindungen zur bekämpfung von endoparasiten | |
| CY1106964T1 (el) | Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους | |
| ATE264839T1 (de) | Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungen | |
| DK1385512T3 (da) | Anvendelse af pyridoindolonderivater til fremstilling af anticancerlægemidler | |
| NO20033073L (no) | Farmasöytisk sammensetning inneholdende citalopram | |
| EE05380B1 (et) | FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid | |
| DK1492781T3 (da) | N,N'-disubstituerede piperazinforbindelser og deres anvendelse som smertestillende midler | |
| SI1496904T1 (sl) | Uporaba zdravil, ki vsebujejo N,N'-disubstituirane piperazinske spojine | |
| EP1453813A4 (en) | IMPROVED PURIFICATION OF 4,4- (5 -) - DI-t-BUTYL CYCLO HEXANO-18-KRONE-6 | |
| FI20012242A0 (fi) | Uudet farmaseuttiset yhdisteet | |
| EE200300563A (et) | Bensüülaminopürimidiiniühendid, nende kasutamine ja ravim | |
| NO20040866L (no) | Ny oral forlenget frigivelses doseringsform |